U.S. FDA removes clinical hold on Investigational New Drug application for COVID-19-Influenza Combination and stand-alone influenza vaccine candidates Achieved total ...
Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...
The number of COVID cases increased last week to 146. Cases had been falling in April and May and were as low as 31 at the ...
Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...
Leerink Partners analyst Mani Foroohar assigned a Sell rating on Moderna (MRNA – Research Report) on November 7 and set a price target of ...
Local health care providers and the Wyoming Department of Health are recommending that most people consider getting a ...
There are around 80 deaths each year from norovirus in the UK, typically older adults and immunocompromised patients. Anyone ...
Hosted on MSN4d
Should Kids Get the COVID-19 Vaccine?The Centers for Disease Control and Prevention (CDC) recommends the Moderna and Pfizer-BioNTech COVID-19 vaccines for kids as ...
Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...
Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Moderna (MRNA – Research Report) today and set a price ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
A WINTER ‘quadruple-demic’ of nasty viruses is set to strike the UK in just weeks. RSV, a potentially lethal lung infection, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback